Discussion  by unknown
This study has shown that in probably less than 1% of
operations were there avoidable surgical errors resulting in
reoperation. However, errors may be concealed in the early
mortality, which is why it has also been reported here.
The overall 86% 20-year Kaplan-Meier survival in this
group is encouraging for a group containing patients oper-
ated on many years ago. The early mortality has declined so
much in most centers that the overall survival must improve,
but most patients should be observed to detect any need for
reoperation, which can be achieved with low mortality.
However, the inevitable group of reoperations will probably
not reduce much and we should continue to consider oper-
ations for congenital heart disease as repairs rather than
corrections.
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Appendix
Procedures Performed in Fewer Than 15 Patients
Mitral valve disease (repair) (10)
Pulmonary atresia with intact ventricular septum (9)
Hypoplastic heart syndrome (8)
Univentricular heart and other (13)
Aortic valve disease (aortic valve replacement) (8)
Mitral valve disease (mitral valve replacement) (8)
Major aortopulmonary collaterals with other anomalies (5)
Supravalvular aortic stenosis (5)
Absent pulmonary valve syndrome (4)
Anomalous origin of coronary arteries (4)
Hemianomalous pulmonary venous drainage (3)
Hypoplastic aortic arch (3)
Tricuspid regurgitation (including Ebstein anomaly) (5)
Cor triatriatum (3)
Other (22)
Total (111)
Discussion
Dr Marshall L. Jacobs (Philadelphia, Pa). It is a particular
pleasure for me to have the opportunity to discuss Mr Monro’s
paper, as I am one of more than a dozen members of this Asso-
ciation who had the opportunity to train with Mr Monro at the
Wessex Cardiothoracic Center in Southampton.
What has been presented here this afternoon is the product of
an archival database reflecting 25 years of experience in the
management of infants and children with congenital heart disease.
Although it was perhaps less apparent 25 years ago, the importance
of this archival process is all too apparent today. Quality assurance
and quality improvement, outcomes research in general, are mere
phrases without the discipline and the diligence to prospectively
record accurate clinical data. For his pioneering effort in this
regard with respect to congenital heart disease, Mr Monro deserves
a great deal of credit.
This analysis focuses on issues of reoperation and survival.
Entry into the overall data set required that a child underwent a
primary repair with CPB. Reoperations were assigned to 1 of 3
categories: inevitable, planned, or unexpected.
In some instances, as, for example, with respect to partial
AVSD, changes in surgical strategy led to a significant reduction
in the need for secondary operations. In other instances, such as the
move toward staging of single ventricle repairs, a strategy that
virtually ensures the need for secondary operations, resulted in a
significant survival advantage.
Mr Monro, I have a few questions:
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1. The exclusion of patients whose primary procedure did not
involve CPB may have resulted in elimination from consid-
eration of some diagnoses, pulmonary atresia with intact
ventricular septum, for example, in which initial manage-
ment might be a so-called “closed procedure,” a shunt, but
which inevitably leads to either univentricular or biventricu-
lar repair with CPB. Might not the elimination of the re-
quirement of a primary pump procedure in the creation of
this database give a potentially more complete and accurate
picture of the patient population and their risks for reopera-
tion and mortality (which, of course, is very valuable infor-
mation)?
2. If in fact changes in surgical technique result in diminution
of the need for reoperations, as you illustrated was true for
partial AVSDs, is it truly accurate to categorize those sec-
ondary operations, operations for mitral regurgitation, as
inevitable? I do not take any issue with the importance of
breaking down the categories. I certainly agree with the
importance of minimizing the unexpected and certainly
agree that some are planned. My very minor point would be
the suggestion that perhaps the term anticipated would be as
accurate as inevitable.
Mr Monro. Thank you very much, Marshall.
Your first point is well taken. We had to stop somewhere and
I decided that we would just include patients who had initial repair
on CPB. This excluded some that I had done previous repairs on
before 1976, when this study started. It excluded a lot of patients
with patent ductus artriosus, coarctation, and so on. Every patient
who had a primary CPB operation is included. There are several
with pulmonary atresia and intact septum in this group, but a
relatively small number. As I say, we had to stop somewhere.
With regard to your point about how did we define what was
inevitable, I think I like your suggestion of anticipated better. I
agree that with partial AVSD, when you have to go back later to
repair the mitral valve, should it be inevitable or not? As I
mentioned, if you get a patient who develops a right ventricular
outflow tract obstruction 2 years after repair of tetralogy of Fallot,
having had a low right ventricular/left ventricular pressure ratio at
the end of the operation, is that inevitable or is it unexpected? We
put it in the unexpected group, but it might be fairer to call it
inevitable or anticipated. So it was difficult, but we just tried to
classify the reoperations into what seemed the most appropriate
groups. As you say, we must try to keep the unexpected group as
small as possible.
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